[CHRS] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
06-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 7.53%
YoY- 57.31%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 64,979 77,063 91,524 74,568 58,716 32,436 45,352 27.11%
PBT -12,921 102,875 -79,653 -40,021 -42,869 -75,729 -58,870 -63.64%
Tax 0 1,464 -10,611 -380 11,560 -949 7,377 -
NP -12,921 102,875 -79,653 -39,641 -42,869 -74,780 -66,247 -66.40%
Tax Rate - -1.42% - - - - - -
Total Cost 77,900 -25,812 171,177 114,209 101,585 107,216 111,599 -21.32%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -19.88 133.49 -87.03 -53.16 -73.01 -230.55 -146.07 -73.57%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.11 0.91 -0.71 -0.41 -0.49 -0.94 -0.85 -74.44%
EPS Diluted -0.11 0.82 -0.71 -0.41 -0.49 -0.94 -0.85 -74.44%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.